← Back to Search

N/A

Antibiotic Use Reports for Infections (VAST Trial)

N/A
Waitlist Available
Led By Robin Lynn Paige Jump, MD PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* VA medical centers without local ID expertise that pair with an ID-expert from another VA medical center.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2.25 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether providing quarterly reports on a facility's antibiotic usage will help reduce overall antibiotic use.

Who is the study for?
This trial is for VA medical centers lacking local infectious disease (ID) expertise. These centers will partner with an ID expert from another VA facility to implement the program.
What is being tested?
The study tests if quarterly reports on antibiotic use can improve a telehealth program called VAST, which aims to reduce unnecessary antibiotic prescriptions at rural VA medical centers by connecting them with distant ID experts.
What are the potential side effects?
Since this trial focuses on implementing a stewardship program rather than direct patient interventions, it does not involve side effects in the traditional sense of medication or treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2.25 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2.25 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Days of Antibiotic Therapy / 1000 Bed Days of Care
Secondary study objectives
Antibiotic Starts
Rate of broad-spectrum antibiotics

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VAST+Experimental Treatment1 Intervention
Sites that implement the VAST augmented by quarterly facility-level Antibiotic Use Reports (VAST+).
Group II: VAST -Active Control1 Intervention
to sites that implement the VAST and do NOT receive a quarterly facility-level Antibiotic Use Reports (VAST-).

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,780 Total Patients Enrolled
Robin Lynn Paige Jump, MD PhDPrincipal InvestigatorVA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Charlesnika Tyon Evans, PhD MPH BSPrincipal InvestigatorEdward Hines Jr. VA Hospital, Hines, IL

Media Library

Videoconference Antimicrobial Stewardship Team (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05319561 — N/A
~1 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top